▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2115 by analyst upside · 2026-08-12
HCAT
Health Catalyst, Inc.
Healthcare · Market Cap $132M · P/E 0x
ANALYST PRICE TARGET
+24.3%
implied upside to consensus target
Current Price $1.76
Consensus Target $2.19
Bull Target $3.0
Bear Target $1.75
Analysts Covering 4
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
1
Hold
3
Sell
0
52-Week Low $0.95
52-Week High $3.8
YTD Return -22.8%
FUNDAMENTALS
Market Cap $132M
P/E Ratio (TTM) N/A
Forward P/E 44.3x
EPS (TTM) $-3.68
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $292M
Profit Margin -90.6%
52-WEEK RANGE
52-Week Low $0.95
52-Week High $3.8
Current Price $1.76
Bear Target $1.75
Bull Target $3.0
● Now $1.76 ● Target $2.19
TRADING DATA
Avg Volume 1.6M
YTD Return -22.8%
Analyst Count 4
Consensus Hold
Upside to Target +24.3%
Last Updated 2026-08-12

ANALYST SUMMARY

Health Catalyst, Inc. (HCAT) is currently trading at $1.76 with a Wall Street consensus price target of $2.19, implying potential upside of 24.3% over the next 12 months. 4 analysts currently cover HCAT, with a consensus rating of Hold - 25% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $3.0, while the most cautious has a target of $1.75.

HCAT operates in the Healthcare sector with a market capitalisation of $132M. The stock is down 22.8% year-to-date and is currently trading near the lower end of its 52-week range of $0.95 – $3.8.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

ORMP +47.1%
Oramed Pharmaceuticals Inc.
$177M · P/E 1.6x · Hold
PDEX +4.9%
Pro-Dex, Inc.
$213M · P/E 18.4x · Buy
SPOK +22.4%
Spok Holdings, Inc.
$239M · P/E 20.1x · Hold
OPRX +79.2%
OptimizeRx Corporation
$130M · P/E 19.2x · Buy
WW +88.8%
WW International, Inc.
$150M · P/E 1.5x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for HCAT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Stephens & Co. - Reiterated
Equal-Weight → Equal-Weight 2026-05-12 Building track record
Wells Fargo ↓ Downgrade
Overweight → Equal-Weight 2026-03-18 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-03-13 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-03-13 Building track record
Stephens & Co. - Reiterated
Equal-Weight → Equal-Weight 2026-03-13 Building track record
Stifel - Reiterated
Hold → Hold 2026-03-13 Building track record
Cantor Fitzgerald - Reiterated
Neutral → Neutral 2026-03-13 40% win rate (10 calls)
Citigroup - Reiterated
Neutral → Neutral 2026-01-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
30
out of 100
Coverage depth
12/30
Consensus clarity
16/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →